Qi Shen

ORCID: 0000-0002-9062-8955 · 6 papers in corpus
observational 2024
BMC pregnancy and childbirth ·doi:10.1186/s12884-024-06597-7

BACKGROUND: This study was designed to evaluate pregnancy outcomes between morulae transferred on day 4 (D4) and blastocysts transferred on day 5 (D5). METHODS: From September 2017 to September 2020, 1963 fresh transfer cycles underwent ea…

observational 2024
PeerJ ·doi:10.7717/peerj.18635

BACKGROUND: The basal luteinizing hormone (LH) and the prior LH to follicle-stimulating hormone (FSH) ratio (LH/FSH) in polycystic ovarian syndrome (PCOS) are generally higher than those in non-PCOS patients and the general population. The …

lab-animal 2019
Drug design, development and therapy ·doi:10.2147/dddt.s212157

PURPOSE: To investigate the role of IGF-1 signaling pathway in the treatment of uterine leiomyomas with mifepristone. PATIENTS AND METHODS: From October 2015 to December 2018, 50 patients with uterine leiomyoma were included in this study.…

other 2018
Journal of translational medicine ·doi:10.1186/s12967-018-1430-x

BACKGROUND: Medical therapeutic options remain quite limited for uterine fibroids treatment. Statins, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, have anti-tumoral effects on multiple cancer types, however, li…

observational 2017
Medicine ·doi:10.1097/md.0000000000006680

To investigate the association between widespread use of mifepristone in abortions and risk of uterine leiomyomas.We conducted a case-control study of 305 patients with uterine leiomyomas between January 2011 and July 2012; 311 women with o…

lab-animal 2016
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2016/2393640

Aims. To observe the effects of Guizhi Fuling Capsule (GZFLC) drug serum on uterine leiomyoma cells and explore its mechanism. Main Methods. Sixty Sprague Dawley rats were randomly divided into two groups (normal saline lavage group and GZF…